Gelclair at Conditioning or After Oral Mucositis Diagnosed vs. Magic Mouth Wash in Stem Cell Transplant Recipients
An Adaptive Design, Single-Blind, Randomized, Controlled Study Investigating Polyvinylpyrrolidone (PVP) and Sodium Hyaluronate-Containing Oral Gel (Gelclair®) in Comparison to Viscous Lidocaine, Diphenhydramine, and Aluminum-magnesium Hydroxide/Simethicone Antacid Suspension Mouthwash (Magic Mouthwash) for the Management of Oral Mucositis Associated With High Dose Chemotherapy and Methotrexate in Allogeneic Stem Cell Transplant Recipients
Sponsor: Midatech Pharma US Inc.
Terminated
low recruitment
A PHASE4 clinical study on Oral Mucositis, this trial is terminated or withdrawn. The trial is conducted by Midatech Pharma US Inc. and has accumulated 7 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE4
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE4
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE4
-
Feb 2020 — Jan 2021 [monthly]
Terminated PHASE4
-
Dec 2019 — Feb 2020 [monthly]
Terminated PHASE4
Status: Recruiting → Terminated
▶ Show 2 earlier versions
-
Jun 2018 — Dec 2019 [monthly]
Recruiting PHASE4
-
May 2018 — Jun 2018 [monthly]
Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Midatech Pharma US Inc.
- PharPoint Research, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .